Healthcare>Healthcare>Healthcare Services>Healthcare Research Analytics & Technology
₹566.10
7.20 (1.29%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹2.53K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
32.2
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Healthcare Research Analytics & Technology
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹376.05+50.5%
52W High₹902.65-37.3%
Current Price
₹566.10
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹452.88
Upper Circuit₹679.32
Reference Price
₹566.10
Investment Checklist
Triple Bottom on 1D (BREAKOUT CONFIRMED) — target ₹615.5
Triple Bottom on 1D (BREAKOUT CONFIRMED) — target ₹612.65
Trend: Price above all key MAs — strong uptrend
EMA(9) Crossover: Price crossed above EMA(9): Fresh bullish momentum signal.
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
81%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend
EMA20
558.08
EMA50
527.34
EMA200
547.69
Price Action
DOWNTREND
BEARISH
Higher Highs2
Higher Lows3
Lower Highs7
Lower Lows6
Support & Resistance Levels
Resistance (Above)
₹578.20
₹594.38
₹602.15
₹610.67
₹625.35
Support (Below)
₹511.80
₹489.90
₹460.00
₹446.15
₹435.85
Volume Analysis
TrendDECREASING
Change-65.60%
Unusual VolumeNo
Stop Loss Levels
Fixed Risk
1% Risk₹560.44
3% Risk₹549.12
5% Risk₹537.79
7% Risk (Custom)
₹526.47Technical Levels
1x ATR (Volatility)₹543.24
2x ATR (Swing)₹520.38
3x ATR (Trend)₹497.52
Immediate Support₹511.80
Moving Averages
EMA 9 (Short-term)₹564.52
EMA 20 (Medium-term)₹558.08
EMA 50 (Trend)₹527.34
EMA 200 (Long-term)₹547.69
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹94.4 Cr | ₹97.6 Cr | ₹101.8 Cr | ₹98.6 Cr |
| Net Profit | ₹18.3 Cr | ₹18.9 Cr | ₹19.9 Cr | ₹17.6 Cr |
| EPS | — | ₹4.25 | ₹4.46 | ₹3.96 |
| Operating Profit | ₹34.6 Cr | ₹35.4 Cr | ₹36.9 Cr | ₹34.4 Cr |
ROE
17.78%
ROCE
23.33%
Debt/Equity
0.02
Current Ratio
2.92
OPM
34.92%
NPM
17.83%
Peer Comparison
Healthcare Research Analytics & TechnologyPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Syngene International Limited | ₹420.35 | +1.19% | 53.0 | ₹16.94K Cr small Cap | |
| Indegene Limited | ₹509.30 | +2.69% | 29.8 | ₹12.25K Cr small Cap | |
| Suven Life Sciences Limited | ₹357.85 | +3.20% | — | ₹8.14K Cr small Cap | |
| Vimta Labs Limited | ₹566.10 | +1.29% | 32.2 | ₹2.53K Cr small Cap | |
| Take Solutions Limited | ₹22.66 | -4.02% | 88.9 | ₹335 Cr small Cap | |
| Bilcare Limited | ₹63.06 | -2.40% | — | ₹148 Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 18 Jun 2026 | Dividend - Rs 2 Per Share | DIVIDEND |
| 13 Jun 2025 | Bonus 1:1 | BONUS |
| 30 May 2025 | Dividend - Rs 2 Per Share | DIVIDEND |
| 11 Jul 2024 | Annual General Meeting/Dividend - Rs 2 Per Share | AGM |
| 21 Jun 2023 | Annual General Meeting/Dividend - Rs 2 Per Share | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for VIMTALABS
View AllNEWS
positive
Business Standard - Markets 65d ago
Vimta Labs standalone net profit rises 15.23% in the March 2026 quarter
Sales rise 15.68% to Rs 109.25 crore
VIMTALABSHealthcare